PDCD1 and neoplasm: A recent OS-specific study elegantly demonstrated this principle using a multifunctional CaCO3-based nanoplatform that simultaneously neutralized tumor acidity and delivered a lactate-suppressing agent, resulting in enhanced CD8+ T cell infiltration and improved efficacy of PD-1 blockade (149).